BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 33562077)

  • 1. Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine.
    Moldogazieva NT; Mokhosoev IM; Zavadskiy SP; Terentiev AA
    Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33562077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection.
    Caviglia GP; Abate ML; Petrini E; Gaia S; Rizzetto M; Smedile A
    Hepatol Res; 2016 Mar; 46(3):E130-5. PubMed ID: 26082262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
    Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
    Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular Carcinoma.
    Ahn KS; O'Brien DR; Kim YH; Kim TS; Yamada H; Park JW; Park SJ; Kim SH; Zhang C; Li H; Kang KJ; Roberts LR
    Liver Cancer; 2021 Nov; 10(6):593-605. PubMed ID: 34950182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Preoperative Hepatocellular Carcinoma With High
    Yamao T; Yamashita YI; Imai K; Umezaki N; Tsukamoto M; Kitano Y; Arima K; Miyata T; Nakagawa S; Okabe H; Hayashi H; Chikamoto A; Ishiko T; Baba H
    Anticancer Res; 2019 Feb; 39(2):883-889. PubMed ID: 30711971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
    Sterling RK; Jeffers L; Gordon F; Venook AP; Reddy KR; Satomura S; Kanke F; Schwartz ME; Sherman M
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):104-13. PubMed ID: 18849011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma.
    Sassa T; Kumada T; Nakano S; Uematsu T
    Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1387-92. PubMed ID: 10654799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current clinical uses of the biomarkers for hepatocellular carcinoma.
    Huang J; Zeng Y
    Drug Discov Ther; 2014 Apr; 8(2):98-9. PubMed ID: 24815586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
    Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J
    PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china.
    Song P; Gao J; Inagaki Y; Kokudo N; Hasegawa K; Sugawara Y; Tang W
    Liver Cancer; 2013 Jan; 2(1):31-9. PubMed ID: 24159594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker development for hepatocellular carcinoma early detection: current and future perspectives.
    Sengupta S; Parikh ND
    Hepat Oncol; 2017 Oct; 4(4):111-122. PubMed ID: 30191058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study.
    Li GJ; Chen QY; Harrison TJ; Wang XY; Hu LP; Yang QL; Li KW; Fang ZL
    Cancer Biomark; 2017; 18(3):241-248. PubMed ID: 28085009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.
    Shimauchi Y; Tanaka M; Kuromatsu R; Ogata R; Tateishi Y; Itano S; Ono N; Yutani S; Nagamatsu H; Matsugaki S; Yamasaki S; Tanikawa K; Sata M
    Oncol Rep; 2000; 7(2):249-56. PubMed ID: 10671666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.
    Hadziyannis E; Sialevris K; Georgiou A; Koskinas J
    Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.
    Song PP; Xia JF; Inagaki Y; Hasegawa K; Sakamoto Y; Kokudo N; Tang W
    World J Gastroenterol; 2016 Jan; 22(1):262-74. PubMed ID: 26755875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy.
    Byeon H; Lee SD; Hong EK; Lee DE; Kim BH; Seo Y; Joo J; Han SS; Kim SH; Park SJ
    Pathol Res Pract; 2018 Jun; 214(6):814-820. PubMed ID: 29753515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
    Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
    Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellualar carcinoma serum markers.
    Bertino G; Ardiri A; Malaguarnera M; Malaguarnera G; Bertino N; Calvagno GS
    Semin Oncol; 2012 Aug; 39(4):410-33. PubMed ID: 22846859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for the early diagnosis of hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.